Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSIGLITAZONE Cause Pleural effusion? 290 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 290 reports of Pleural effusion have been filed in association with ROSIGLITAZONE. This represents 0.6% of all adverse event reports for ROSIGLITAZONE.

290
Reports of Pleural effusion with ROSIGLITAZONE
0.6%
of all ROSIGLITAZONE reports
52
Deaths
272
Hospitalizations

How Dangerous Is Pleural effusion From ROSIGLITAZONE?

Of the 290 reports, 52 (17.9%) resulted in death, 272 (93.8%) required hospitalization, and 1 (0.3%) were considered life-threatening.

Is Pleural effusion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSIGLITAZONE. However, 290 reports have been filed with the FAERS database.

What Other Side Effects Does ROSIGLITAZONE Cause?

Myocardial infarction (17,018) Cardiac failure congestive (15,085) Cerebrovascular accident (7,899) Coronary artery disease (4,982) Acute myocardial infarction (2,437) Cardiac disorder (1,732) Coronary arterial stent insertion (1,698) Coronary artery bypass (1,181) Chest pain (990) Myocardial ischaemia (970)

What Other Drugs Cause Pleural effusion?

DASATINIB (2,424) METHOTREXATE (1,310) CYCLOPHOSPHAMIDE (1,239) IBRUTINIB (1,205) RITUXIMAB (1,168) PREDNISONE (1,144) NIVOLUMAB (1,061) ADALIMUMAB (1,036) DEXAMETHASONE (879) PACLITAXEL (862)

Which ROSIGLITAZONE Alternatives Have Lower Pleural effusion Risk?

ROSIGLITAZONE vs ROSUVASTATIN ROSIGLITAZONE vs ROSUVASTATIN\ROSUVASTATIN ROSIGLITAZONE vs ROTIGOTINE ROSIGLITAZONE vs ROXADUSTAT ROSIGLITAZONE vs ROXICODONE

Related Pages

ROSIGLITAZONE Full Profile All Pleural effusion Reports All Drugs Causing Pleural effusion ROSIGLITAZONE Demographics